FCGR3A and neoplasm: Thus the unifying observations from both treatment studies strongly suggest that the in vivo anti-tumor activity of h1567 is mediated, at least in large part, by ADCC through engagement of FcγRIIIA on mouse neutrophils (model 1) and human NK cells (model 2).